- Home
- BXP vs TECH Comparison
BXP vs TECH Comparison
Compare BXP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BXP | TECH |
|---|---|---|
| Founded | 1970 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.2B |
| IPO Year | 1997 | 1989 |
Fundamental Metrics
Financial Performance| Metric | BXP | TECH |
|---|---|---|
| Price | $64.03 | $65.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | ★ $76.95 | $70.46 |
| AVG Volume (30 Days) | 1.6M | ★ 2.1M |
| Earning Date | 01-27-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.29% | 0.47% |
| EPS Growth | ★ 1833.33 | N/A |
| EPS | ★ 1.74 | 0.49 |
| Revenue | ★ $3,482,279,000.00 | $1,216,732,000.00 |
| Revenue This Year | $2.98 | $2.33 |
| Revenue Next Year | $0.98 | $6.89 |
| P/E Ratio | ★ $37.48 | $140.18 |
| Revenue Growth | 3.02 | ★ 3.85 |
| 52 Week Low | $54.22 | $46.01 |
| 52 Week High | $79.33 | $79.28 |
Technical Indicators
Market Signals| Indicator | BXP | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 34.83 | 50.90 |
| Support Level | $65.47 | $66.94 |
| Resistance Level | $65.93 | $68.54 |
| Average True Range (ATR) | 1.71 | 2.45 |
| MACD | -0.15 | -0.22 |
| Stochastic Oscillator | 23.97 | 26.11 |
Price Performance
Historical ComparisonAbout BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.